Abstract

Despite increasing economic pressure on hospitals to reduce stay length, it often is difficult to assess how shortening stays affects patient outcomes. International investigators used data from the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-1) trial to determine the cost-effectiveness of hospitalization beyond 72 hours …

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call